Nagalingeswaran Kumarasamy

Nagalingeswaran Kumarasamy

UNVERIFIED PROFILE

Are you Nagalingeswaran Kumarasamy?   Register this Author

Register author
Nagalingeswaran Kumarasamy

Nagalingeswaran Kumarasamy

Publications by authors named "Nagalingeswaran Kumarasamy"

Are you Nagalingeswaran Kumarasamy?   Register this Author

99Publications

3003Reads

14Profile Views

Advanced HIV: diagnosis, treatment, and prevention.

Lancet HIV 2019 Aug 5;6(8):e540-e551. Epub 2019 Jul 5.

Chennai Antiviral Research and Treatment Clinical Research Site, Voluntary Health Services, Chennai, India. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3018(19)30189-4DOI Listing
August 2019

The Cost-effectiveness of HIV Pre-exposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.

Clin Infect Dis 2019 Mar 28. Epub 2019 Mar 28.

Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz249DOI Listing
March 2019

Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multi-country randomised, non-inferiority trial.

J Acquir Immune Defic Syndr 2018 Nov 12. Epub 2018 Nov 12.

Chief Medical Officer, YRG Centre for AIDS Research & Education, Voluntary Health Services, Tidal Park Road, Taramani, Chennai 600113, India. Address: YRGCARE Medical Centre, VHS, Chennai, INDIA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001908DOI Listing
November 2018

Attitudes of Indian HIV Clinicians Toward Depression in People Living with HIV.

Ann Glob Health 2016 Sep - Oct;82(5):792-797

Y.R. Gaitonde Centre for AIDS Research and Education, Chennai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aogh.2016.04.672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347478PMC
May 2018

Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.

Antivir Ther 2017 14;22(3):205-213. Epub 2016 Oct 14.

Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392175PMC
March 2018

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.

J Acquir Immune Defic Syndr 2017 12;76(4):388-393

*Department of Pathology, Johns Hopkins Hospital, Baltimore, MD;†Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;‡Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD;§FHI 360, Washington, DC;‖FHI 360, Durham, NC;¶Research Institute for Health Sciences, Chiang Mai University, Chaing Mai, Thailand;#University of North Carolina at Chapel Hill, Chapel Hill, NC;**UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi;††YRGCARE Medical Centre, VHS, Chennai, India;‡‡College of Medicine-Johns Hopkins Project, Blantyre, Malawi;§§Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil;‖‖Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil;¶¶Hospital Nossa Senhora da Conceição, Porto Alegre RS, Brazil;##Botswana Harvard AIDS Institute, Gaborone, Botswana;***Kenya Medical Research Institute, Kisumu, Kenya;†††Center for Disease Control, Kisumu, Kenya;‡‡‡University of the Witwatersrand, Perinatal HIV Research Unit, Soweto HPTN CRS, Soweto, South Africa;§§§University of Witwatersrand, Johannesburg, South Africa;‖‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and¶¶¶Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00126334-201712010-0000
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000001511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659928PMC
December 2017

HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.

J Acquir Immune Defic Syndr 2017 11;76(3):319-329

*The Kirby Institute, UNSW, Sydney, New South Wales, Australia; †Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Fundacion Huesped, Buenos Aires, Argentina; §University of Chile School of Medicine & Fundación Arriaran, Santiago, Chile; ‖School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; ¶Children's Hospital 2, Ho Chi Minh City, Vietnam; #Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; **University of Calgary, Calgary, Alberta, Canada; ††YRGCARE Medical Centre, Chennai, India; ‡‡Pediatric Infectious Disease Division, Escola Paulista de Medicina-Universidade Federal de SãoPaulo, São Paulo, Brazil; §§Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD; ‖‖Division of Infectious Diseases, Department of Medicine, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa; and ¶¶Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634924PMC
November 2017

Neurocognitive functioning among HIV-positive adults in southern India.

J Neurovirol 2017 10 5;23(5):750-755. Epub 2017 Jul 5.

Department of Medicine, University of California, San Diego 9500 Gilman Drive, MC 8231, La Jolla, CA, 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13365-017-0546-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656514PMC
October 2017

HIV and Aging: Demographic Change in the Asia-Pacific Region.

J Acquir Immune Defic Syndr 2017 04;74(5):e146-e148

*The Kirby Institute, UNSW Australia, Sydney, New South Wales, Australia†YRGCARE Medical Centre, Chennai, India‡The University of Health Sciences with the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia§Tan Tock Seng Hospital, Singapore, Singapore‖National Hospital for Tropical Diseases, Hanoi, Vietnam¶Faculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia#Bach Mai Hospital, Hanoi, Vietnam**Queen Elizabeth Hospital, Hong Kong, China††Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea‡‡TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341141PMC
April 2017

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial.

J Acquir Immune Defic Syndr 2017 Jan;74(1):112-116

*Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; †Laboratory of Immunoregulation, NIAID, NIH, Baltimore, MD; ‡Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC; §Vaccine and Infectious Disease Science Division, Fred Hutchinson Cancer Research Institute, Seattle, WA; ‖Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; ¶Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, DIR, NIAID, NIH, Hamilton, MT; #Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; **Science Facilitation Department, FHI360, Washington, DC; ††Science Facilitation Department, FHI360, Durham, NC; ‡‡College of Medicine-Johns Hopkins Project, Blantyre, Malawi; §§UNC Project, Lilongwe, Malawi; ‖‖Department of Medicine, University of Zimbabwe, Harare, Zimbabwe; ¶¶HIV Research Branch, Center for Global Health, Kenya Medical Research Institute (KEMRI)-Centers for Disease Control (CDC), Kisumu, Kenya; ##BHHRL & Clinical Trials Unit, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; ***Soweto HPTN CRS, Chris Hani Baragwanath Hospital, Soweto, South Africa; †††YRGCARE Medical Centre, Chennai, India; ‡‡‡Center for AIDS and STDs, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; §§§Hospital Nossa Senhora da Conceição, Serviço de Infectologia, Porto Alegre, Brazil; ‖‖‖Hospital Geral de Nova Iguaçu and Laboratorio de AIDS e Imunologia Molecular (IOC/Fiocruz), Rio de Janeiro, Brazil; ¶¶¶Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil; ###Fenway Health and Infectious Disease Division, The Fenway Institute, Boston, MA; ****Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA; ††††Vaccine and Infectious Disease Division and Public Health Science Division, Fred Hutchinson Cancer Research Institute, Seattle, WA; ‡‡‡‡Department of Biostatistics, University of Washington, Seattle, WA; and §§§§Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140698PMC
January 2017

A pseudo-random patient sampling method evaluated.

J Clin Epidemiol 2017 01 19;81:129-139. Epub 2016 Oct 19.

The Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney, NSW 2052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2016.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318236PMC
January 2017

Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation.

J Acquir Immune Defic Syndr 2016 10;73(2):123-9

*Division of Infectious Diseases, Center for Global Health, Weill Cornell Medical College, New York, NY; †Johns Hopkins Clinical Trials Unit, Byramjee Jeejeebhoy Government Medical College, Pune, India; ‡Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD; §Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA; ‖Department of Medicine, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe; ¶Division of Infectious Diseases, Hospital Nossa Senhora de Conceição, Porto Alegre, Brazil; #Les Centres GHESKIO, Port-Au-Prince, Haiti; **Department of Medicine, University of North Carolina-Lilongwe, Lilongwe, Malawi; ††Research Institute for Health Sciences, Chiang Mai, Thailand; ‡‡Impacta Peru, San Miguel, Peru; §§Durban International Clinical Research Site, Durban University of Technology, Durban, South Africa; ‖‖STD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil; ¶¶Department of Medicine, University of Witwatersrand, Johannesburg, South Africa; ##National AIDS Research Institute (ICMR), Pune, India; ***Malawi College of Medicine-Johns Hopkins University Research Project, Blantyre, Malawi; †††YRGCARE Medical Center, Chennai, India; ‡‡‡Investigative Medicine Branch, Laboratório Integrado de Microbiologia e Imunorregulação (LIMI), Centro de Pesquisas Gonçalo Moniz (CPqGM), Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil; §§§Division of Infectious Diseases, University of Colorado-Denver, Aurora, CO; ‖‖‖Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; and ¶¶¶Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023467PMC
October 2016

Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

N Engl J Med 2016 09 18;375(9):830-9. Epub 2016 Jul 18.

From the Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill (M.S.C., M.C.H., I.F.H., J.E.); the Divisions of Vaccine and Infectious Disease (Y.Q.C., X.C.Z.) and Public Health Science (Y.Q.C.) and the Statistical Center for HIV/AIDS Research and Prevention (L.C.), Fred Hutchinson Cancer Research Center, and the Department of Biostatistics, University of Washington (T.R.F.) - both in Seattle; FHI 360, Washington, DC (M.M.), and Durham, NC (T.G.); Y.R. Gaitonde Center for AIDS Research and Education, Chennai (N.K.), and National AIDS Research Institute, Pune (S.V.G.) - both in India; University of Zimbabwe, Harare (J.G.H.); College of Medicine-Johns Hopkins Project, Blantyre, Malawi (J.K.); Instituto de Pesquisa Clinica Evandro Chagas (B.G.) and Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz (J.H.S.P.), Rio de Janeiro, and Servico de Infectologia, Hospital Nossa Senhora da Conceicao/GHC, Porto Alegre (B.R.S.) - both in Brazil; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand (S.C.); Fenway Institute (K.H.M.) and Harvard School of Public Health (M.E.) - both in Boston; the Departments of Pathology (S.H.E., E.P.-M., S.E.H.) and Medicine (A.D.R.), Johns Hopkins University School of Medicine, the Department of Epidemiology, Bloomberg School of Public Health (T.E.T.), and Johns Hopkins Bloomberg School of Public Health (D.D.C.), Baltimore, and the Division of AIDS (V.E., D.B.) and Laboratory of Immunoregulation (A.D.R.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda - both in Maryland; Botswana Harvard AIDS Institute, Gaborone (J.M.); Centers for Disease Control and Prevention (CDC) Division of HIV/AIDS Prevention/KEMRI-CDC Research and Public Health Collaboration HIV Research Branch, Kisumu, Kenya (L.A.M.); Perinatal HIV Research Unit (R.P.) and Clinical HIV Research Unit, Department of Medicine, Faculty of Health Scien

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049503PMC
http://dx.doi.org/10.1056/NEJMoa1600693DOI Listing
September 2016

Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.

Medicine (Baltimore) 2016 Aug;95(32):e4570

aDepartment of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea bThe Kirby Institute, UNSW Australia, Sydney, Australia cInstitute of Infectious Disease and Epidemiology, Communicable Disease Centre, Tan Tock Seng Hospital, Singapore, Singapore dWorking Group on AIDS Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta, Indonesia eInfectious Diseases Department, Bach Mai Hospital, Hanoi, Vietnam fQueen Elizabeth Hospital and Integrated Treatment Centre, Hong Kong, China gHospital Sungai Buloh, Sungai Buloh, Malaysia hHIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand iTaipei Veterans General Hospital, Taipei, Taiwan jUniversity Malaya Medical Centre, Kuala Lumpur, Malaysia kBeijing Ditan Hospital, Capital Medical University, Beijing, China lInstitute of Infectious Diseases, Pune, India mResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand nNational Center for Global Health and Medicine, Tokyo, Japan oHospital Raja Perempuan Zainab II, Kota Bharu, Malaysia pChennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India qNational Hospital for Tropical Diseases, Hanoi, Vietnam rResearch Institute for Tropical Medicine, Manila, Philippines sFaculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand tFaculty of Medicine, Udayana University and Sanglah Hospital, Bali, Indonesia uTREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985340PMC
August 2016

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

J Acquir Immune Defic Syndr 2016 07;72(3):304-9

1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; 2Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 3Frontier Science & Technology Research Foundation, Amherst, NY; 4Specialty Molecular Division, Lancet Laboratories and BARC-SA, Johannesburg, South Africa; 5Laboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; 6Y. R. Gaitonde Centre for AIDS Research and Education, Chennai, India; 7National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India; 8Science Facilitation Department, FHI 360, Washington, DC; 9Science Facilitation Department, FHI 360, Durham, NC; 10Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; 11Southwest CARE Center, Santa Fe, NM; 12College of Medicine-Johns Hopkins Project, Blantyre, Malawi; 13Botswana Harvard AIDS Institute, Gaborone, Botswana; 14YRGCARE Medical Centre, VHS, Chennai, India; 15Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; 16Department of Medicine, University of Zimbabwe, Harare, Zimbabwe; 17Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa; 18Kenya Medical Research Institute, Center for Disease Control, Kisumu, Kenya; 19Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; 20UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; 21Serviço de Infectologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; 22Department of Epidemiology and Biostatistics, National AIDS Research Institute (ICMR), Pune, India; 23Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil; 24Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil; 25Perinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS, S

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911290PMC
July 2016

Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia.

Pediatr Infect Dis J 2016 May;35(5):e144-51

From the *The Kirby Institute, UNSW Australia, Sydney, Australia; †Department of Pediatrics, Faculty of Medicine, Chiang Mai University and Research Institute for Health Sciences, Chiang Mai, Thailand; ‡Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; §Hospital Likas, Kota Kinabalu, Malaysia; ¶Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; ‖National Centre for HIV/AIDS Dermatology and STDs, Phnom Penh, Cambodia; **Children's Hospital 1, Ho Chi Minh City, Vietnam; ††Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; ‡‡National Hospital of Pediatrics, Hanoi, Vietnam; §§Children's Hospital 2, Ho Chi Minh City, Vietnam; ¶¶HIV-NAT, the Thai Red Cross AIDS Research Centre, Bangkok, Thailand; ‖‖Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; ***Hospital Raja Perempuan Zainab II, Kelantan, Malaysia; †††YRGCARE Medical Centre, CART CRS, Chennai, India; ‡‡‡Sanglah Hospital, Udayana University, Bali, Indonesia; §§§Pediatric Institute, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; and ¶¶¶Members of TREAT Asia Pediatric HIV Observational Database are listed in Appendix.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000001074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829479PMC
May 2016

Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.

J Infect Dis 2016 Jan 14;213(2):250-6. Epub 2015 Jul 14.

Division of Infectious Diseases, Stanford University, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690149PMC
January 2016

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

J Acquir Immune Defic Syndr 2015 Oct;70(2):163-71

*Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; †Department of Medicine, University of California Davis, Sacramento, CA; ‡Department of Medicine, University of Colorado Denver, Aurora, CO; §Harvard University Center for AIDS Research, Harvard School of Public Health, Boston, MA; ‖University of North Carolina Project, Lilongwe, Malawi; ¶Instituto de Pesquisa Clinica Evandro Chagas, Manguinhos, Brazil; #Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; **Department of Medicine, Chiang Mai University, Chiang Mai, Thailand; ††Department of Medicine, University of Witwatersrand, Johannesburg, South Africa; ‡‡IMPACTA PERU Clinical Trials Unit, Asociacion Civil Impacta Salud y Educacion, Lima, Peru; §§Department of Pulmonology, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa; ‖‖Malawi College of Medicine-Johns Hopkins Research Project, Kachere Rehabilitation Centre, Blantyre, Malawi; ¶¶National AIDS Research Institute, Pune, India; ##Les Centres GHESKIO, Port-au-Prince, Haïti; ***YR Gaitonde Center for AIDS Research and Education, Chennai, India; †††Department of Medicine, University of Zimbabwe, Harare, Zimbabwe; ‡‡‡Department of Medicine, University of California Davis, Sacramento, CA; and §§§Department of Ophthalmology, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573329PMC
October 2015

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

J Acquir Immune Defic Syndr 2015 Jul;69(3):e85-92

*Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea; †The Kirby Institute, UNSW Australia, Sydney, Australia; ‡Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India; §Working Group on AIDS Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; ‖Research Institute for Health Sciences, Chiang Mai, Thailand; ¶Queen Elizabeth Hospital, Hong Kong, China; #Hospital Sungai Buloh, Sungai Buloh, Malaysia; **National Center for Global Health and Medicine, Tokyo, Japan; ††Taipei Veterans General Hospital, Taipei, Taiwan; ‡‡University Malaya Medical Centre, Kuala Lumpur, Malaysia; §§Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; ‖‖HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand; ¶¶Tan Tock Seng Hospital, Singapore; ##Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ***Beijing Ditan Hospital, Capital Medical University, Beijing, China; †††Institute of Infectious Diseases, Pune, India; ‡‡‡Research Institute for Tropical Medicine, Manila, Philippines; §§§Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ‖‖‖Faculty of Medicine, Udayana University and Sanglah Hospital, Bali, Indonesia; ¶¶¶National Center for HIV/AIDS, Dermatology and STDs, and University of Health Sciences, Phnom Penh, Cambodia; and ###TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506699PMC
July 2015

Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children.

Pediatr Infect Dis J 2015 Jun;34(6):e153-8

*Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; †HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; ‡TB/HIV Department, National Pediatric Hospital, Phnom Penh, Cambodia; §The Kirby Institute, University of New South Wales, Sydney, Australia; ¶Department of Child Health, Sanglah Hospital, Udayana University, Bali, Indonesia; ‖Infectious Disease Department, National Hospital of Pediatrics, Hanoi, Vietnam; **Research Unit, National Center for HIV/AIDS, Dermatology and STDs, Social Health Clinic, Phnom Penh, Cambodia; ††Faculty of Medicine, University of Health Sciences, Phnom Penh, Cambodia; ‡‡Department of Pediatrics, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; §§Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ¶¶Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; ‖‖Infectious Disease Department, Children's Hospital 1, Ho Chi Minh City, Vietnam; ***Infectious Disease Department, Children's Hospital 2, Ho Chi Minh City, Vietnam; †††Y.R. Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India; ‡‡‡Department of Pediatrics, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia; §§§Pediatric Institute, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; ¶¶¶Pediatric Allergy-Immunology Division, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; ‖‖‖Department of Pediatrics, Hospital Likas, Kota Kinabalu, Malaysia; ****Department of Pediatrics, Penang Hospital, Penang, Malaysia; and ††††TREAT Asia/amfAR-The Foundation for AIDS Research, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000693DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435819PMC
June 2015

Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.

J Acquir Immune Defic Syndr 2015 Jun;69(2):234-40

*Department of Psychiatry, Massachusetts General Hospital, Boston, MA; †Department of Medicine, Harvard Medical School, Boston, MA; ‡Department of Medicine, Fenway Health, Boston, MA; §Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA; ‖Vaccine and Infectious Disease Division, Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ¶Science Facilitation Department, FHI 360, Washington, DC; #HIV/AIDS Clinical Trials Unit, Instituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil; **Division of Infectious Diseases, University of North Carolina at Chapel Hill, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; ††CART CRS, YRGCARE Medical Centre, YRG CARE Medical Center, VHS Chennai CRS, Chennai, India; ‡‡Science Facilitation Department, FHI 360, Durham, NC; §§Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC; and ‖‖Department of Epidemiology, John Hopkins University, Bloomberg School of Public Health, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445420PMC
June 2015

Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients: week 48 results of the ARIEL trial.

Pediatr Infect Dis J 2015 May;34(5):e132-7

From the *Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; †Helios Salud, Buenos Aires, Argentina; ‡Gaitonade Center for AIDS Research and Education (YRG CARE), VHS, Chennai, India; §Department of Infectious Diseases, Hospital Geral De Nova Iguacu & Laboratório de AIDS e Imunologia Molecular, Fiocruz/IOC, Rio De Janeiro, Brazil; ¶Janssen Infectious Diseases BVBA, Beerse, Belgium; and ‖Janssen Research & Development LLC, Titusville, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/INF.0000000000000644DOI Listing
May 2015

A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.

J Acquir Immune Defic Syndr 2014 Dec;67(4):e131-3

*The Kirby Institute, UNSW Australia, Sydney, Australia †National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia ‡Queen Elizabeth Hospital, Hong Kong, China §HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand ‖Bach Mai Hospital, Hanoi, Vietnam ¶Hospital Sungai Buloh, Sungai Buloh, Malaysia #YRGCARE Medical Centre, VHS, Chennai, India **National Hospital for Tropical Diseases, Hanoi, Vietnam ††Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand ‡‡University Malaya Medical Centre, Kuala Lumpur, Malaysia §§Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand ‖‖Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213211PMC
December 2014